PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2124175
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2124175
According to Mordor Intelligence, the rehabilitation equipment market size expanded to USD 18.86 billion in 2025, is estimated to reach USD 20.16 billion in 2026, and is projected to grow to USD 28.12 billion by 2031, registering a CAGR of 6.88% between 2026 and 2031.

This report is Segmented by Product Type (Daily Living Aids [Medical Beds, and More], Mobility Equipment, Exercise Equipment, and Body Support Devices), Application (Physiotherapy, Occupational Therapy, Neuro-Rehabilitation, and More), End User (Hospitals, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).
Hospitals are discharging patients sooner, shifting recovery workloads onto skilled nursing facilities, outpatient clinics, and homes. Stroke remains a pivotal public health concern, with roughly 795,000 annual events in the United States alone, each requiring months of intensive therapy. Orthopedic cases add volume, as hip and knee replacements climb among aging adults across developed markets. Diabetes, COPD, and heart failure add steady demand, since supervised exercise and education lower mortality by up to 30%. Value-based payment models reward fewer readmissions, pushing providers to adopt equipment that accelerates mobility gains and measures progress. Together, these factors are driving the rehabilitation equipment market toward data-rich devices that demonstrate improved outcomes.
FDA clearances and emerging billing codes are shifting exoskeletons from research labs to clinics. Ekso NR received U.S. clearance in 2024, enabling data-guided gait therapy that improves weight-bearing symmetry. Lifeward reported a 40% increase in hospital uptake for ReStore after Medicare introduced a dedicated G-code reimbursing up to USD 150 per session. Japan widened nursing-care insurance in 2025 to subsidize exoskeleton rentals, reducing caregiver injuries. AI algorithms now adjust resistance in real time, extending therapy sessions while lowering therapist fatigue. As batteries shrink and component prices fall, small centers and even select home programs begin leasing units, widening the footprint of the rehabilitation equipment market.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Robotic and smart systems are set to expand at a 12.85% CAGR through 2031, nearly double the overall rehabilitation equipment market. Mobility equipment retained a 37.55% share in 2025, underscoring durable demand for manual and powered wheelchairs. Manual chairs remain volume leaders for short-term needs, while powered variants gain ground as insurers now fund advanced seating that prevents pressure sores. Daily living aids such as smart beds with weight sensors alert caregivers to unassisted exits, lowering fall risk and extending independent living. Exercise equipment is evolving into connected platforms that gamify motion and feed adherence metrics to therapists.
Robotic exoskeletons, gait trainers, and upper-limb robots are shifting momentum. A 2025 meta-analysis recorded 18% greater motor recovery in stroke patients receiving robotic-assisted therapy compared with matched conventional doses. With clinical evidence accumulating, payers are opening dedicated billing codes, positioning robotics to capture a growing share of the rehabilitation equipment market by 2031. Traditional suppliers are responding through joint ventures and acquisitions aimed at embedding AI modules into wheelchairs, lifts, and beds, signaling an era where software usability competes with mechanical durability.
North America preserved 42.52 of % rehabilitation equipment market share in 2025, led by the United States, where Medicare Advantage enrollment reached 31 million and bundled rehabilitation benefits encourage adoption of powered wheelchairs and connected exercise gear. Canada's provincial formularies fund mobility aids, while its tele-rehabilitation pilots bridge therapist gaps in rural zones. A competitive mix of legacy suppliers and robotics start-ups operates through hospital GPO contracts, home-health agencies, and direct web sales.
Europe exhibits diverse reimbursement climates. Germany updated its Hilfsmittelverzeichnis in 2024 to include exoskeletons, enabling statutory coverage when evidence shows they outperform conventional therapy. The United Kingdom grapples with budget ceilings, favoring lower-cost connected exercise equipment for community rehab teams. France covers up to 100% of device costs depending on severity, stimulating demand for smart beds and adaptive bathrooms. Spain and Italy witness private centers offering VR therapies ahead of public adoption. The Medical Device Regulation's stringent evaluation rules encourage consolidation, nudging small manufacturers toward partnerships.
Asia-Pacific leads in growth at a 9.12% CAGR. China's plan to open 10,000 rehabilitation hospitals by 2030 subsidizes 50-70% of qualifying equipment purchases. Japan's 2025 nursing-care reforms hike payments for robotic lifts to mitigate caregiver strain. India's Production Linked Incentive scheme supports domestic manufacturing, though the market still favors imported mid-range devices. Australia and South Korea exploit high broadband penetration to deploy tele-rehabilitation, while Middle East, Africa, and South America progress steadily through medical tourism and private hospital expansion. Across regions, localized manufacturing incentives and digital-health investments will continue to diversify rehabilitation equipment market demand patterns.